297 words
Lilly breaks ground in Richmond to expand American manufacturing of next-generation cancer medicines, advancing its build-out of 10 new U.S. sites since 2020
First Lilly site to produce both active pharmaceutical ingredients and finished medicines in a fully integrated facility Site will create 650 high-wage jobs The facility will produce antibody-drug conjugates (ADCs), targeted cancer treatments designed to combine the precision of antibodies with…